Given the strong association between SHBG levels and MetS and T2DM, as well as evidence that genetic-raising alleles lower risk for these metabolic disorders [33,34], some authors have proposed a role for SHBG in the pathogenesis of IR and T2DM [158]. This evidence concerns the gene SHBG and metabolic disease.